<DOC>
	<DOCNO>NCT02212990</DOCNO>
	<brief_summary>This study aim conduct double-blind , placebo-controlled study assess effect prophylactic antipyretic immune response rate fever inactivate influenza vaccine ( IIV ) child 6 47 month age . In study , 160 healthy child , 6 47 month age , include child risk febrile seizure , randomize one three different treatment arm . Children receive either blind therapy prophylactic acetaminophen placebo immediately follow every 4 6 hour 24 hour receipt dose IIV open-label ibuprofen every 6 8 hour 24 hour receipt dose IIV . Children follow occurrence fever , fussiness , change appetite sleep pattern , use medical service day two day follow vaccination . Antibody influenza antigen contain respective 2014-2015 2015-2016 vaccine measure hemagglutination inhibition ( HAI ) antibody assess baseline four week follow vaccination . The proportion child experience fever , solicit side effect , use medical service , demonstrate serologic response correspond seroprotection seroconversion IIV antigen determine group child three treatment arm . Likewise geometric mean HAI titer ( GMTs ) correspond 95 % confidence interval IIV antigen calculate three treatment arm . The investigator hope learn whether prophylactic antipyretic affect immune response fever rate follow IIV .</brief_summary>
	<brief_title>The Effect Prophylactic Antipyretics Immune Responses Fever After 2014-2015 2015-2016 Inactivated Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antipyretics</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>1 . The child must 6 47 month age . 2 . The child must weigh 5.4 kilogram . 3 . The child must receive IIV season . 4 . If child two year age old need two dos influenza vaccine season parent/guardian intend child receive IIV second dose . 5 . The parent/guardian must willing capable provide write informed consent child . 6 . The parent/guardian must available followup must minimum telephone access . 7 . The parent/guardian must agree sign medical release child study personnel may obtain medical information child 's health ( need ) . 1 . History receipt current year 's licensed influenza vaccine . 2 . Planned receipt live attenuate nasally administer influenza vaccine year 3 . History severe allergic reaction ( e.g . anaphylaxis ) component influenza vaccine , include egg protein , formaldehyde , octylphenol ethoxylate , gelatin , thimerosal use thimerosal contain vaccine . 4 . History severe allergic reaction ( e.g . anaphylaxis ) follow prior dose influenza vaccine . 5 . History allergic reaction follow acetaminophen ingredient acetaminophen product . 6 . History allergic reaction follow ibuprofen ingredient ibuprofen product . 7 . History allergic reaction follow aspirin pain reliever fever reducer . 8 . History liver disease . 9 . Currently take blood thin drug warfarin ( Coumadin ) blood thinner . 10 . History recent plan heart surgery within past 3 month next 3 month . 11 . History stomach ulcer bleed problem . 12 . Currently already routinely take prescription nonprescription nonsteroidal antiinflammatory drug NSAIDs ( aspirin , ibuprofen , naproxen , others ) 13 . Received licensed vaccine within 14 day ( inactivated vaccine ) 28 day ( live vaccine ) prior vaccination study expect receive license vaccine 28 day follow last influenza vaccination study . Concomitant vaccination allow . 14 . Routine immunization delay delay able receive concomitantly administer vaccine need vaccine 28 day follow last influenza vaccination study . 15 . Received experimental/investigational agent ( vaccine , drug , biologic , device , blood product , medication ) within 28 day prior vaccination study , expect receive experimental/investigational agent within followup time period ( 28 day last vaccination study ) . 16 . A moderate severe acute illness and/or report temperature great equal 100.0°F ( 37.8°C ) within 72 hour prior first dose IIV axillary temperature great equal 100.0°F ( 37.8°C ) time enrollment . ( This may result temporary delay vaccination . For need second dose IIV , moderate severe acute illness and/or report temperature great equal 100.0°F ( 37.8°C ) within 72 hour prior second dose IIV may result temporary delay vaccination ) . 17 . Receipt antipyretic medication ( acetaminophen ibuprofen ) within 72 hour prior first dose IIV ( This may result temporary delay vaccination ) already plan administer prophylactic antipyretic medication day day follow dose IIV ( exclusion apply caretaker indicate he/she might administer antipyretic vaccination reduce fever ) . 18 . Immunosuppression result underlie illness treatment , use anticancer chemotherapy radiation therapy within precede 36 month . 19 . Long term ( least 14 day prednisone 2 mg/kg/day equivalent glucocorticoid ) , parenteral steroid , highdose inhaled steroid ( &gt; 800 mcg/day beclomethasone dipropionate equivalent ) within precede 6 month ( topical nasal steroid allow ) . 20 . History GuillainBarré syndrome within 6 week prior dose influenza vaccine . 21 . Has condition would , opinion site investigator , place participant unacceptable risk injury render participant unable meet requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>47 Months</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Fever</keyword>
	<keyword>Antipyretics</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Influenza</keyword>
	<keyword>Body temperature change</keyword>
	<keyword>Signs symptom</keyword>
</DOC>